Viral Hepatitis Management
During hepatitis infection a high calorie diet is required along with moderate physical activity. The important step in the management of hepatitis is the intake of correct drug with correct dosage and frequency. Hepatitis A does not progress into chronic condition and hence the management requires supportive treatment such as intravenous administration of fluid and nutrition. In most cases hepatitis B results into chronic state and hence drug treatment is mandatory. The drugs used for the treatment of hepatitis B include interferon alpha, Pegylated interferon, Lamivudine, Adefovir dipivoxi, Telbivudine and Tenofovir. The drugs used in the management of hepatitis C include telaprevir, boceprevir, dasabuvir. The treatment of hepatitis D is difficult and lacks specific anti-viral drugs. The management of Hepatitis E includes bed rest along with supplementation of proper nutrition.
Related Conference of Viral Hepatitis Management
14th International Conference on COPD Clinical Trials & Lung Care Advances
18th International Conference on Chronic Obstructive Pulmonary Disease
16th International Conference on Pulmonary & Respiratory Medicine
7th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Viral Hepatitis Management Conference Speakers
Recommended Sessions
- Advancement in New Drug Discovery for Treatment of Hepatitis
- Critical Care and Hepatology Nursing
- Epidemiology of Hepatitis
- Hepatitis Care
- Hepatocellular Carcinoma
- Intestinal Rehabilitation
- Liver Cancer
- Liver Diseases Diagnosis
- Liver Fibrosis
- Liver Transplantation and Surgery
- Molecular Biology of Hepatitis A, B, C, D and E Viruses
- Pancreatic Diseases
- Pathophysiology of Hepatitis
- Pediatric Gastroenterology, Hepatology and Nutrition
- Pregnancy and Liver Diseases
- Recent Advances in the Viral Hepatitis C Treatment
- Types of Hepatitis
- Viral Hepatitis Management
Related Journals
Are you interested in
- Acute Exacerbations and Intensive Care - COPD_2026 (UAE)
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- Advances in COPD Pharmacotherapy - COPD_2026 (UAE)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- Artificial Intelligence & Digital Health in Respiratory Medicine - COPD SUMMIT 2026 (Italy)
- Asthama - Copd 2026 (France)
- Asthma & Airway Diseases - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Chronic Bronchitis - Copd 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Copd 2026 (France)
- Clinical Research and Translational Medicine - COPD_2026 (UAE)
- COPD - COPD SUMMIT 2026 (Italy)
- COPD Comorbidities and Multidisciplinary Care - COPD_2026 (UAE)
- COPD Epidemiology and Public Health - COPD_2026 (UAE)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis and Molecular Mechanisms - COPD_2026 (UAE)
- COPD Phenotypes and Precision Medicine - COPD_2026 (UAE)
- COPD: Emerging Therapies & Disease Management - COPD SUMMIT 2026 (Italy)
- COPD: Prevention, Diagnosis & Management - COPD SUMMIT 2026 (Italy)
- Coronavirus (COVID-19) - Copd 2026 (France)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Critical Care Pulmonology & Mechanical Ventilation - COPD SUMMIT 2026 (Italy)
- Current Research & Innovations in Pulmonology - COPD SUMMIT 2026 (Italy)
- Cystic Fibrosis - Copd 2026 (France)
- Digital Health, Telemedicine and Artificial Intelligence in COPD - COPD_2026 (UAE)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Early Diagnosis, Screening and Biomarkers - COPD_2026 (UAE)
- Emphysema - Copd 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Environmental Pollution and Occupational Lung Diseases - COPD_2026 (UAE)
- Future Directions in COPD & Lung Diseases - COPD SUMMIT 2026 (Italy)
- Future Innovations in COPD and Respiratory Healthcare - COPD_2026 (UAE)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases (ILD) - COPD SUMMIT 2026 (Italy)
- Interventional pulmonology - Copd 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Lung Cancer - Copd 2026 (France)
- Lung Cancer & Thoracic Oncology - COPD SUMMIT 2026 (Italy)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Diseases - COPD SUMMIT 2026 (Italy)
- Lung Imaging and Pulmonary Function Technologies - COPD_2026 (UAE)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Occupational & Environmental Lung Diseases - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pneumonia - COPD SUMMIT 2026 (Italy)
- Pneumonia - Copd 2026 (France)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Arterial Hypertension - Copd 2026 (France)
- Pulmonary Fibrosis - COPD SUMMIT 2026 (Italy)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation & Respiratory Care - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation and Chronic Care - COPD_2026 (UAE)
- Respiratory Diagnostics & Lung Function Testing - COPD SUMMIT 2026 (Italy)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Respiratory Infections and Lung Microbiome - COPD_2026 (UAE)
- Respiratory Medicine and Pulmonology - COPD_2026 (UAE)
- Respiratory Tract Infections - Copd 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Medicine & Sleep-Related Breathing Disorders - COPD SUMMIT 2026 (Italy)
- Stages & Severity on Lung Diseases - Copd 2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
- Tuberculosis - COPD SUMMIT 2026 (Italy)
